Kwang Dong Pharmaceutical Co., Ltd. (009290.KS)
KRW 5670.0
(0.0%)
KRW 5670.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 913.39 KRW | 55.22% |
| 2022 | 588.45 KRW | 0.64% |
| 2021 | 584.68 KRW | -47.77% |
| 2020 | 1119.49 KRW | 92.44% |
| 2019 | 581.72 KRW | 5.58% |
| 2018 | 551.00 KRW | -3.67% |
| 2017 | 572.00 KRW | -17.34% |
| 2016 | 692.00 KRW | -20.28% |
| 2015 | 868.00 KRW | -0.12% |
| 2014 | 869.00 KRW | 61.52% |
| 2013 | 538.00 KRW | -19.46% |
| 2012 | 668.00 KRW | -2.2% |
| 2011 | 683.00 KRW | 23.73% |
| 2010 | 552.00 KRW | 11.07% |
| 2009 | 497.00 KRW | 11.19% |
| 2008 | 447.00 KRW | -8.59% |
| 2007 | 489.00 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 42.36 KRW | -92.73% |
| 2024 Q1 | 454.09 KRW | 228.93% |
| 2023 FY | - KRW | 55.22% |
| 2023 Q4 | 138.05 KRW | -37.34% |
| 2023 Q3 | 220.32 KRW | 4.68% |
| 2023 Q2 | 210.48 KRW | -38.43% |
| 2023 Q1 | 341.87 KRW | 96.53% |
| 2022 Q1 | 185.00 KRW | 10.49% |
| 2022 Q2 | 73.03 KRW | -60.52% |
| 2022 FY | - KRW | 0.64% |
| 2022 Q3 | 157.00 KRW | 114.98% |
| 2022 Q4 | 173.95 KRW | 10.8% |
| 2021 Q3 | 218.00 KRW | 282.46% |
| 2021 Q1 | 150.00 KRW | 190.75% |
| 2021 Q2 | 57.00 KRW | -62.0% |
| 2021 FY | - KRW | -47.77% |
| 2021 Q4 | 167.43 KRW | -23.2% |
| 2020 Q2 | 272.00 KRW | 0.74% |
| 2020 Q3 | 743.00 KRW | 173.16% |
| 2020 Q1 | 270.00 KRW | 334.22% |
| 2020 FY | - KRW | 92.44% |
| 2020 Q4 | -165.29 KRW | -122.25% |
| 2019 Q1 | 229.00 KRW | 444.59% |
| 2019 Q3 | 104.00 KRW | -44.09% |
| 2019 FY | - KRW | 5.58% |
| 2019 Q4 | 62.18 KRW | -40.21% |
| 2019 Q2 | 186.00 KRW | -18.78% |
| 2018 Q2 | 119.00 KRW | -33.52% |
| 2018 Q3 | 211.00 KRW | 77.31% |
| 2018 Q4 | 42.05 KRW | -80.07% |
| 2018 FY | - KRW | -3.67% |
| 2018 Q1 | 179.00 KRW | 156.48% |
| 2017 Q1 | 155.00 KRW | 196.93% |
| 2017 Q4 | 69.79 KRW | -72.42% |
| 2017 Q3 | 253.00 KRW | 169.15% |
| 2017 FY | - KRW | -17.34% |
| 2017 Q2 | 94.00 KRW | -39.35% |
| 2016 Q2 | 237.00 KRW | 20.92% |
| 2016 Q3 | 206.00 KRW | -13.08% |
| 2016 Q4 | 52.20 KRW | -74.66% |
| 2016 FY | - KRW | -20.28% |
| 2016 Q1 | 196.00 KRW | 32.55% |
| 2015 Q4 | 147.87 KRW | -40.38% |
| 2015 FY | - KRW | -0.12% |
| 2015 Q3 | 248.00 KRW | -9.82% |
| 2015 Q2 | 275.00 KRW | 39.59% |
| 2015 Q1 | 197.00 KRW | 3.03% |
| 2014 Q3 | 282.00 KRW | 22.08% |
| 2014 Q2 | 231.00 KRW | 40.0% |
| 2014 FY | - KRW | 61.52% |
| 2014 Q1 | 165.00 KRW | 26.95% |
| 2014 Q4 | 191.20 KRW | -32.2% |
| 2013 Q3 | 250.00 KRW | 1370.59% |
| 2013 Q4 | 129.97 KRW | -48.01% |
| 2013 FY | - KRW | -19.46% |
| 2013 Q1 | 141.00 KRW | -9.71% |
| 2013 Q2 | 17.00 KRW | -87.94% |
| 2012 Q2 | 171.00 KRW | 31.54% |
| 2012 Q3 | 199.00 KRW | 16.37% |
| 2012 Q4 | 156.16 KRW | -21.53% |
| 2012 FY | - KRW | -2.2% |
| 2012 Q1 | 130.00 KRW | -11.56% |
| 2011 Q4 | 147.00 KRW | -18.33% |
| 2011 Q2 | 199.00 KRW | 44.2% |
| 2011 Q3 | 180.00 KRW | -9.55% |
| 2011 Q1 | 138.00 KRW | 9.37% |
| 2011 FY | - KRW | 23.73% |
| 2010 Q3 | 169.00 KRW | 11.18% |
| 2010 Q2 | 152.00 KRW | 53.54% |
| 2010 Q1 | 99.00 KRW | -22.41% |
| 2010 Q4 | 126.18 KRW | -25.34% |
| 2010 FY | - KRW | 11.07% |
| 2009 FY | - KRW | 11.19% |
| 2009 Q4 | 127.60 KRW | -24.05% |
| 2009 Q3 | 168.00 KRW | 55.56% |
| 2009 Q1 | 91.00 KRW | 46.94% |
| 2009 Q2 | 108.00 KRW | 18.68% |
| 2008 Q3 | 182.00 KRW | 82.0% |
| 2008 Q2 | 100.00 KRW | 0.0% |
| 2008 FY | - KRW | -8.59% |
| 2008 Q4 | 61.93 KRW | -65.97% |
| 2008 Q1 | 100.00 KRW | -21.15% |
| 2007 Q4 | 126.83 KRW | -21.16% |
| 2007 Q2 | 117.00 KRW | 42.28% |
| 2007 Q1 | 82.23 KRW | 0.0% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q3 | 160.86 KRW | 37.49% |